logo

Intersect Ent Inc (XENT)



Trade XENT now with
  Date
  Headline
5/21/2018 8:09:44 AM SetPoint Medical Appoints Ankit Shah To Lead Commercialization And Marketing
1/8/2018 8:19:43 AM Intersect ENT 2017 Revenue Up 22% Year Over Year
1/7/2018 9:50:22 AM New Drugs Approved In December
12/11/2017 8:29:05 AM Intersect ENT Trading Halted; Expected To Resume At 8:30 AM ET
12/11/2017 8:07:38 AM Intersect ENT Unveils FDA Approval Of SINUVA Sinus Implant For Recurrent Nasal Polyps
11/3/2017 9:19:17 AM Wedbush Is Lowering Intersect ENT Inc (XENT) 2017 Estimate To -0.66 From -0.63
11/3/2017 9:18:54 AM Wedbush Is Raising Intersect ENT Inc (XENT) 2018 Rev. Estimate To 112.7 M From 111.6 M
11/3/2017 9:18:40 AM Wedbush Is Increasing Intersect ENT Inc (XENT) 2017 Rev. Estimate To 94.6 M From 93.5 M
10/8/2017 12:44:50 PM Intersect ENT Presents Results From RESOLVE II, Pivotal Phase III Study Evaluating Safety And Efficacy Of SINUVA
8/2/2017 12:41:31 PM Wedbush Is Lowering Intersect ENT Inc (XENT) 2018 Rev. Estimate To 111.6 M From 112.0 M
8/2/2017 12:41:10 PM Wedbush Is Raising Intersect ENT Inc (XENT) 2017 Rev. Estimate To 93.5 M From 91.1 M
8/2/2017 12:40:36 PM Wedbush Is Increasing Intersect ENT Inc (XENT) Q4 17 Rev. Estimate To 27.8 M From 27.7 M
8/2/2017 12:40:13 PM Wedbush Is Increasing Intersect ENT Inc (XENT) Q3 17 Rev. Estimate To 21.3 M From 20.4 M
8/2/2017 12:39:47 PM Wedbush Is Increasing Intersect ENT Inc (XENT) 2017 Estimate To -0.63 From -0.72
8/2/2017 12:39:24 PM Wedbush Is Cutting Intersect ENT Inc (XENT) Q3 17 Estimate To -0.26 From -0.24
7/20/2017 4:12:06 PM Intersect ENT Appoints Teresa Kline To Board Of Directors